SOD1 and amyotrophic lateral sclerosis: And knockdown of mutant SOD1 in astrocytes results in a significant rescue of astrocyte-derived toxicity toward motor neurons, indicating that mutant SOD1 in astrocytes can be recognized as a potential therapeutic target for ALS (Haidet-Phillips et al., 2011).